Form 4 for DRMA Dermata Therapeutics, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-17 · accession 0000905718-21-001104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-17 | 2021-08-17 | DRMA | WIERENGA WENDELL | Dir | C - Cnv Deriv | — | +8,163 | 13.0K | +167% | — |
| D | 2021-08-17 | 2021-08-17 | DRMA | WIERENGA WENDELL | Dir | C - Cnv Deriv | $0.00 | -55.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | C | A | 8,163 | — | 13,041 | D | — | — | (F1) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. |
| 2 | Derivative | Series 1d Preferred Stock | 2021-08-17 | C | D | 55,078 | $0.00 | 0 | D | — · — to — | 8,163 Common Stock | (F1) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. |